Ferring gets rights to BioSET's orthobiologic assets
Ferring Pharmaceuticals AS acquired rights from BioSurface Engineering Technologies Inc. (BioSET) to assets designed to improve bone health, including Phase III-ready orthobiologics Amplex and Prefix.
- Medical Devices
- Site Specific
- Drug Delivery
- Implantable Devices
- Large Molecule
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.